New drug improves abnormalities associated with metabolic syndrome
A newly developed drug for treating metabolic syndrome safely reduces plasma triglycerides and LDL cholesterol, and reverses NAFLD and liver insulin resistance, according to a study published inScience Translational Medicine.MedicalXpress
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Cholesterol | Endocrinology | Insulin | Liver | Metabolic Syndrome | Non-alcoholic Fatty Liver Diseases (NAFLD) | Study | Urology & Nephrology